Toxic epidermal necrolysis after sulfasalazine treatment of mild psoriatic arthritis: warning on the use of sulfasalazine for a new indication.
Jullien
D
D
Hôpital Henri Mondor, University of Paris XI, Créteil, France.
Wolkenstein
P
P
Roupie
E
E
Roujeau
J C
JC
Revuz
J
J
D000328:Adult; D015535:Arthritis, Psoriatic / Q000188:drug therapy*; D004817:Epidermis / Q000473:pathology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009336:Necrosis; D012871:Skin Diseases / Q000139:chemically induced* / Q000473:pathology; D012460:Sulfasalazine / Q000009:adverse effects* / Q000627:therapeutic use
D012460:Sulfasalazine